Heart failure and statins—Why do we need a clinical trial?
- 1 April 2005
- journal article
- critical perspective
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 94 (4) , 223-230
- https://doi.org/10.1007/s00392-005-0210-9
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failureThe American Journal of Cardiology, 2004
- Preservation of NO production by statins in the treatment of heart failureCardiovascular Research, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failureInternational Journal of Cardiology, 2000
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Co‐Enzyme Q10: A New Drug for Cardiovascular DiseaseThe Journal of Clinical Pharmacology, 1990
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1990
- Regulation of the mevalonate pathwayNature, 1990